Newsletter Subject

Survival Boost With Oncolytic Virus Combo in Glioblastoma Subset

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, May 19, 2023 08:06 PM

Email Preheader Text

Oncology Update Friday, May 19, 2023 ADVERTISEMENT Exclusives & Features Brooke from Southampton was

[MEDPAGE TODAY]( Oncology Update Friday, May 19, 2023 [Survival Boost With Oncolytic Virus Combo in Glioblastoma Subset]( [ASCO Backs Routine ESR1 Testing for Certain Breast Cancers]( [Adding Mylotarg to Chemo Fails to Boost Survival in NPM1-Mutated AML]( [Immune Checkpoint Inhibitors Safe, Effective in Cancer Patients With HIV]( [ADC Plus Low-Intensity Chemo Promising in Older Patients With B-Cell ALL]( ADVERTISEMENT Exclusives & Features [FDA 'Leans In' to Accelerated Approval for Rare Disease Drugs]( [Lumpers vs Splitters: Categorizing Prostate Cancer]( [Plastic Surgeon Who Livestreamed Procedures on TikTok May Lose License]( [Bereaved parents of brain tumour girl back funding petition]( Brooke from Southampton was diagnosed with brain cancer in April 2019, she died 11 months later. [READ MORE]( [Single-Cell Profiling in Multiple Myeloma: Insights, Problems, and Promises.]( In a short time, single-cell platforms have become the norm in many fields of research, including multiple myeloma (MM). In fact, the large amounts of cellular heterogeneity in MM make single-cell... [READ MORE]( [Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice.]( BACKGROUND: We sought to estimate the proportion of patients with cancer treated with immune checkpoint inhibitors (ICI) who die soon after starting ICI in the real world and to examine factors... [READ MORE]( [A multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer.]( BACKGROUND: Clinical trials reported 25-30% pathologic complete response (pCR) rates in HER2+ breast cancer (BC) patients treated with anti-HER2 therapies without chemotherapy. We hypothesize that a... [READ MORE]( [Lower risk of depression after smoking cessation and alcohol abstinence in patients with gastric cancer who underwent gastrectomy: A population-based, nationwide cohort study.]( BACKGROUND: Although depression is associated with poor treatment outcomes in patients with cancer, little is known about whether lifestyle modifications could help prevent depression. The authors... [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-05-19&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.